Adaptive Biotechnologies Corporation Stock Analysis & AI Score
Adaptive Biotechnologies Corporation (ADPT) has an ST Score of 56.9 (B-), driven by its Profitability (A) and held back by its Financial Strength (D+). Analysts rate it Buy with a $28.10 price target (-5.0% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Adaptive Biotechnologies Corporation (ADPT) has an ST Score of 56.9 (B-), driven by its Profitability (A) and held back by its Financial Strength (D+). Analysts rate it Buy with a $28.10 price target (-5.0% downside).
- Strongest
- ProfitabilityA
- Weakest
- Financial StrengthD+
All factor grades
- ProfitabilityA
- MomentumA-
- GrowthB
- ValuationB-
- ForecastC+
- Financial StrengthD+
- Piotroski4/9
Contact
ADPT stock: frequently asked questions
What is ADPT's ST Score?
Adaptive Biotechnologies Corporation (ADPT) has an ST Score of 56.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ADPT a buy, hold, or sell?
Analysts rate ADPT a Buy, with a price target of $28.10 (-5.0% vs the current price). Our ST Score grades it B- (56.9/100). The ST Score is a data-driven signal, not a recommendation.
What are ADPT's factor grades?
Valuation B-, Profitability A, Financial Strength D+, Momentum A-, Growth B, Forecast C+.
What is ADPT's valuation grade?
Adaptive Biotechnologies Corporation (ADPT) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ADPT's growth grade?
Adaptive Biotechnologies Corporation (ADPT) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ADPT's profitability grade?
Adaptive Biotechnologies Corporation (ADPT) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ADPT's financial strength grade?
Adaptive Biotechnologies Corporation (ADPT) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ADPT?
The average analyst price target for Adaptive Biotechnologies Corporation (ADPT) is $28.10 from 17 analysts, which is -5.0% versus the recent price of $29.57.
What is ADPT's Piotroski score?
Adaptive Biotechnologies Corporation (ADPT) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.